These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21853369)

  • 1. Synthesis of monomethoxypolyethyleneglycol-cholesteryl ester and effect of its incorporation in liposomes.
    Sant VP; Nagarsenker MS
    AAPS PharmSciTech; 2011 Dec; 12(4):1056-63. PubMed ID: 21853369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
    Kleemann E; Schmehl T; Gessler T; Bakowsky U; Kissel T; Seeger W
    Pharm Res; 2007 Feb; 24(2):277-87. PubMed ID: 17211729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Oct; 188(2):193-202. PubMed ID: 10518675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 2000 May; 201(1):37-49. PubMed ID: 10867263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.
    Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN
    Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies.
    Fernández-Carballido A; Pastoriza P; Barcia E; Montejo C; Negro S
    Int J Pharm; 2008 Mar; 352(1-2):50-7. PubMed ID: 18036755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting.
    Su W; Wang H; Wang S; Liao Z; Kang S; Peng Y; Han L; Chang J
    Int J Pharm; 2012 Apr; 426(1-2):170-181. PubMed ID: 22266537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of liposomes formulation and preparation method on the stability of acyclovir palmitate liposomes].
    Liu H; Tang R; He XX; Zhang Y
    Yao Xue Xue Bao; 2002 Jul; 37(7):563-6. PubMed ID: 12914330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New amphiphilic derivatives of poly(ethylene glycol) (PEG) as surface modifiers of colloidal drug carriers. III. Lipoamino acid conjugates with carboxy- and amino-PEG(5000) polymers.
    Pignatello R; Impallomeni G; Pistarà V; Cupri S; Graziano AC; Cardile V; Ballistreri A
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():470-81. PubMed ID: 25492012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
    Jin SE; Kim IS; Kim CK
    Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel mixed polyethyleneglycol modified liposomes.
    Sugiyama I; Sadzuka Y
    Biol Pharm Bull; 2007 Jan; 30(1):208-11. PubMed ID: 17202690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
    Changsan N; Chan HK; Separovic F; Srichana T
    J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity.
    Kuang Y; Liu J; Liu Z; Zhuo R
    Biomaterials; 2012 Feb; 33(5):1596-606. PubMed ID: 22079777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis.
    Jogala S; Rachamalla SS; Aukunuru J
    Curr Drug Deliv; 2016; 13(5):698-710. PubMed ID: 26777886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery.
    Bedu-Addo FK; Tang P; Xu Y; Huang L
    Pharm Res; 1996 May; 13(5):710-7. PubMed ID: 8860425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.